Ashiq Mubarack

Stock Analyst at Citigroup

(2.21)
# 1196
Out of 5,218 analysts
3
Total ratings
100.00%
Success rate
20.24%
Average return
Main Sectors:
Top Industries:
2 Stocks
Name Action Price Target Current % Upside Ratings Updated
Mersana Therapeutics
Maintains: Buy
6 5
2.15 132.56% 2 Aug 27, 2024
Alpha Tau Medical
Initiates Coverage On: Buy
8
3.06 161.44% 1 Dec 15, 2023